Skip to main navigation
Skip to search
Skip to main content
Tohoku University Home
English
日本語
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
View Scopus Profile
Yu Sato
Assistant Professor
University Hospital (not affiliated with any section)
h-index
36
Citations
4
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2015
2023
Research activity per year
Overview
Fingerprint
Network
Research output
(10)
Similar Profiles
(7)
If you made any changes in Pure these will be visible here soon.
Fingerprint
Dive into the research topics where Yu Sato is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Drug
100%
Therapeutic Drug Monitoring
85%
Multiple Sclerosis
78%
Estrogen Receptor Antagonist
42%
CYP3A4
42%
Mycophenolate Mofetil
42%
Itraconazole
42%
Aromatase Inhibitor
42%
Lenvatinib
42%
Cyclin Dependent Kinase 4
42%
Cyclin Dependent Kinase 6
42%
Voriconazole
42%
Hydroxyitraconazole
42%
Polypeptide
36%
Lithocholic Acid
30%
Bile Acid
30%
Anion
30%
Anastrozole
28%
Hormone Receptor
28%
Breast Cancer
28%
Bosutinib
28%
Nilotinib
28%
Methanol
28%
Abemaciclib
28%
Fulvestrant
28%
Imatinib
28%
Ammonium Formate
28%
Palbociclib
28%
Pharmacokinetics
26%
Electrospray Ionization
21%
Dasatinib
21%
Ibrutinib
21%
Side Effect
17%
Anticarcinogen
17%
Protein
14%
Neutropenia
14%
Liver Cell Carcinoma
14%
Ribociclib
14%
Acetonitrile
14%
Immunosuppressive Agent
14%
Letrozole
14%
Chronic Leukemia
14%
Antifungal Agent
14%
Diarrhea
14%
Growth Factor Receptor
14%
Protein Tyrosine Kinase Inhibitor
14%
Pharmacodynamics
14%
Letrozole Plus Ribociclib
14%
Adverse Event
12%
Glycine
11%
Chemistry
Procedure
83%
Mass Spectrometry
55%
Electrosprays
42%
Mycophenolic Acid
42%
Voriconazole
42%
Itraconazole
42%
Metabolite
35%
Liquid
33%
Liquid Chromatography
30%
Mobile Phase Composition
28%
Nilotinib
28%
Bosutinib
28%
Imatinib
28%
Chromatography
28%
Ammonium Formate
28%
Methanol
28%
Sample
26%
Aqueous Solution
25%
Column Like Crystal
25%
Tandem Mass Spectrometry
21%
Analytical Method
21%
Tyrosine Kinase Inhibitor
21%
Ibrutinib
21%
Error
14%
Collisionally Activated Dissociation (CAD)
14%
Quality Control
14%
Protein Precipitation
14%
Flow
14%
Acetonitrile
14%
Antifungal Drug
14%
Retention Time
14%
Cholesterol
10%
Biological Marker
10%
Time
10%
Acid
10%
Safety
7%
Structure
7%
Ion
7%
Plasma Level
7%
Physical Property
7%
Plasma Concentration
7%
Amount
7%
Concentration
5%
Volume
5%
Interference
5%
Glycine
5%
Ammonium
5%
Chemical Reaction
5%
Biochemistry, Genetics and Molecular Biology
Tandem Mass Spectrometry
57%
Mobile Phase Composition
50%
Niemann-Pick Disease
42%
Steroid
42%
CYP3A4
42%
Solution and Solubility
39%
Serine
34%
Phosphorylcholine
34%
Liquid
33%
Mass Spectrometry
28%
Liquid Chromatography Tandem Mass Spectrometry
26%
Liquid Chromatography Mass Spectrometry
24%
Time
22%
Cholesterol
21%
Flow
21%
Urine Sampling
21%
Sample
19%
Screening
18%
Development
16%
Accuracy
15%
Retention Time
14%
Precipitation
14%
Quality Control
14%
Simple Protein
14%
Deoxycholic Acid
14%
Tandem Mass Spectrometry
12%
Analytical Method
11%
Urinalysis
10%
Normal Human
8%
Chromatography
7%
Optimal Drug Dose
7%
Cytochrome P450
7%
Enzyme Activity
7%
Electric Potential
7%
Sampling
7%
Cortisol
7%
Metabolic Pathway
7%
Lysozyme
7%
Glycine
5%
pH
5%
Morphology
5%
Running
5%
Wild Type
5%
Cell Suspension
5%
Suspension Cell Culture
5%
Mass Spectrometry
5%
Volume
5%
Selected Reaction Monitoring
5%
Protein
5%
Staining
5%
